Medicare payments to home health agencies would drop by 1%, or $180 million, in 2017 under a proposed payment rule from CMS.
Isoprene: That is what hypoglycemia-sniffing dogs are actually detecting. (Gizmodo)
GW Pharma said its cannabidiol drug Epidiolex met its endpoints in a phase III trial in Lennox-Gastaut syndrome, the rare seizure disorder.
A Texas woman went into surgery to correct an overbite came out speaking with a sort-of-British accent. (KHOU)
A Pittsburgh company is developing a surgical "snake robot" that can bend around organs and other delicate obstacles. (Pittsburgh Post-Gazette)
If anti-amyloid drugs fail in the current wave of phase III trials, it may be the end of the line for all Alzheimer drug development, at least for pharma companies. (Bloomberg)
Nearly lost in the media storm surrounding the Supreme Court's Texas abortion law ruling was its decision to let stand a lower-court ruling seen as weakening patent protection on novel medical technologies. (Reuters)
Minnesota's Blue Cross affiliate said it would stop selling individual health plans entirely, including those bought directly by consumers and through agents as well as those in the state's Obamacare exchange. (Kaiser Health News)
Physicians need to lend assistance whenever they see an emergency nearby, says Niran Al-Agba, MD. (KevinMD)
A second U.S. patient was tentatively found to be carrying E. coli with the mcr-1 "superbug gene" for colistin resistance. (Reuters)
Morning Break is a daily guide to what's new and interesting on the Web for healthcare professionals, powered by the MedPage Today community. Got a tip? Send it to us: MPT_editorial@everydayhealthinc.com.
Morning Break: Medicare Cut Proposed; Woman Briticized; Weakened Patents
Aucun commentaire:
Enregistrer un commentaire